The discovery that excitatory amino acids can mediate brain damage has opened the way to new potential therapies through drugs that counter their effects. We are at the difficult stage between the excitement of discovery and the sobriety of proof.
All the contributors agree that N-methyl-d-aspartate (NMDA) antagonists prevent neuronal injury "in vitro"
Hachinski V. NMDA Antagonist Protection From Neuronal Injury. Arch Neurol. 1992;49(4):421. doi:10.1001/archneur.1992.00530280115033
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: